SKYE

Skye Bioscience, Inc. Common Stock (SKYE)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 108.77M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 7.47
52W Low
$ 1.14
Dividend Yield
0.00%
Beta
2.21

Technicals

50-Day MA
3.443
200-Day MA
3.0237
52 Week High
7.47
52 Week Low
1.14

About SKYE

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic disease.

Employees
16
Headquarters
San Diego, CA
CEO
Mr. Punit S. Dhillon B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg